How Biotech is Revolutionizing the Fight Against Cancer

Cancer has long been a major health concern for people around the world. According to the World Health Organization (WHO), cancer is the second leading cause of death globally, accounting for nearly 10 million deaths in 2020 alone.

India's Glenmark Life Sciences says Q4 profit soars 48 per cent on API boost

Glenmark Life Sciences Ltd in India reported a 48% increase in fourth-quarter profit on Thursday, owing to growth in its mainstay business of producing active pharmaceutical ingredients (API) for drugs. The Mumbai-based pharmaceutical company's....

PureTech's Vedanta Biosciences Declares $106.5 mn financing to advance pipeline of defined bacterial consortia therapies

Vedanta Biosciences, a clinical-stage company developing a potential new class of oral therapies based on defined bacterial consortia, announced a $106.5 million funding round to support pivotal-stage development of its lead candidate, VE303,...

Alentis Therapeutics Declares positive results from phase 1 multiple-ascending dose cohorts study

Alentis Therapeutics (Alentis), a clinical-stage biotechnology company developing novel treatments for organ fibrosis and CLDN1+ tumours, announced results from its first-in-human phase 1 clinical study of ALE.F02 targeting Claudin-1 (CLDN1)....

WHO Urges Increased Use Of Recommended Malaria-Fighting Tools

The World Health Organisation (WHO) has issued a call for increased implementation of new and existing malaria interventions to save lives on World Malaria Day.Thanks to an ongoing pilot programme coordinated by WHO, nearly 1.5 million children...

Mankind Pharma's IPO Subscribed 87% on day 2 of Issue

On Wednesday, the penultimate day of the sale, Mankind Pharma's initial public offering was subscribed to 87%. Institutional investors subscribed 1.86 times, rich investors 1.02 times, and regular investors 25%. Mankind Pharma distributed Rs 1,298...

I-Mab Declares Positive Outcome In Arbitration Relating To Agreements With Tracon Pharma

I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced the positive outcome of its arbitration with Tracon Pharmaceuticals (Tracon) relating to (1) the...

Nkure raises a pre-Series A financing To Finalise Manufacturing Methods and Preclinical investigations for their Expected IND Application

Nkure Therapeutics, an NK cell therapy startup, has announced the completion of its pre-Series A round, in which Endiya Partners, Kotak Investment Advisors, Featherlite, and a few angel investors participated. Nkure intends to use the funds to....

India Aims for Lucrative South Korean Pharma Market, Signs Agreement with Generic Drug Export Association

As India has the G20 presidency and South Korea is a member of the G20, the Korea Pharmaceuticals & Bio Manufacturers Association (KPBMA) in Seoul has inked a memorandum of understanding (MoU) with India. "The KPBMA has special significance,...

© 2024 India Pharma Outlook. All Rights Reserved.